Recombinant people's interleukin 2 has emerged as a significant factor in immunotherapy for various malignancies . This detailed review investigates its mode of operation, covering its part in stimulating immune cells expansion and NK cell response. We shall discuss clinical uses , difficulties , and prospective pathways for refining its effectiven